Signati Medical Inc. is focused on revolutionizing the field of men's health through its innovative Sealed Vasectomy Procedure (SVP)®. This procedure represents the first significant advancement in vasectomy techniques in over two decades, emphasizing enhanced comfort, safety, and efficiency for both patients and physicians. The SVP™ is designed to be performed in a urologist's office and can be completed in just a few minutes, which not only streamlines the process but also aims to facilitate a quicker recovery for patients compared to traditional vasectomy methods.

The technology behind the SVP™ utilizes a bipolar approach, which is intended to minimize discomfort and improve overall outcomes for patients undergoing the procedure. By prioritizing patient experience and procedural efficiency, Signati Medical is committed to advancing men's health and providing a modern solution to a common medical procedure. The company is actively preparing for the launch of this innovative device, which promises to set a new standard in the field of vasectomy.

United States

Signati Medical, Inc. based in Providence, Rhode Island is an early stage medical device company committed to developing its revolutionary, Sealed Vasectomy Procedure (SVP)™. Signati Medical is dedicated to advancing men's health and plans on launching its product platform in mid 2024.

Signati Medical Inc.

Company Details